Eledon Pharmaceuticals, Inc.
ELDN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $200 | $44 | $33 | $65 |
| - Cash | $21 | $5 | $56 | $85 |
| + Debt | $1 | $0 | $1 | $1 |
| Enterprise Value | $180 | $40 | -$23 | -$19 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$35 | -$116 | -$88 | -$37 |
| % Margin | – | – | – | – |
| Net Income | -$36 | -$117 | -$88 | -$35 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.75 | -1.64 | -6.13 | -2.33 |
| % Growth | 54.3% | 73.2% | -163.1% | – |
| Operating Cash Flow | -$47 | -$40 | -$28 | -$29 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$47 | -$40 | -$28 | -$29 |